150 related articles for article (PubMed ID: 35070392)
1. LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB.
Song Y; Liang Y; Zou Q; Zeng S; Lin H; Liu M; Liu X; Du J; Chen G; Zou L; Su W; Niu F
J Gastrointest Oncol; 2021 Dec; 12(6):2622-2630. PubMed ID: 35070392
[TBL] [Abstract][Full Text] [Related]
2. m
Meng X; Deng Y; He S; Niu L; Zhu H
Front Oncol; 2021; 11():629947. PubMed ID: 33680969
[TBL] [Abstract][Full Text] [Related]
3.
Su W; Wang L; Niu F; Zou L; Guo C; Wang Z; Yang X; Wu J; Lu Y; Zhang J; Beer DG; Yang Z; Chen G
Aging (Albany NY); 2019 May; 11(9):2812-2821. PubMed ID: 31085800
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis.
Chen P; Zeng Z; Wang J; Cao W; Song C; Lei S; Li Y; Ren Z
Cell Death Discov; 2022 Apr; 8(1):198. PubMed ID: 35418193
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA
Pang K; Ran MJ; Zou FW; Yang TW; He F
Oncol Lett; 2018 Aug; 16(2):2119-2124. PubMed ID: 30008909
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer.
Zhang W; Qian W; Gu J; Gong M; Zhang W; Zhang S; Zhou C; Jiang Z; Jiang J; Han L; Wang X; Wu Z; Ma Q; Wang Z
Cancer Lett; 2023 Jan; 552():215976. PubMed ID: 36272615
[TBL] [Abstract][Full Text] [Related]
7.
Su W; Wang L; Zhao H; Hu S; Zhou Y; Guo C; Wu B; Li L; Yang Z; Beer DG; Chen G
Mol Ther Nucleic Acids; 2020 Dec; 22():1164-1175. PubMed ID: 33312753
[TBL] [Abstract][Full Text] [Related]
8. LINC00857 promotes cell proliferation and migration in colorectal cancer by interacting with YTHDC1 and stabilizing SLC7A5.
Tang S; Liu Q; Xu M
Oncol Lett; 2021 Aug; 22(2):578. PubMed ID: 34122629
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway.
Lin X; Feng D; Li P; Lv Y
Cancer Med; 2020 Nov; 9(21):8122-8132. PubMed ID: 32918541
[TBL] [Abstract][Full Text] [Related]
10. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
Huang Y; Lin Y; Song X; Wu D
Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
[TBL] [Abstract][Full Text] [Related]
11. LINC00857 contributes to hepatocellular carcinoma malignancy via enhancing epithelial-mesenchymal transition.
Xia C; Zhang XY; Liu W; Ju M; Ju Y; Bu YZ; Wang W; Shao H
J Cell Biochem; 2019 May; 120(5):7970-7977. PubMed ID: 30506763
[TBL] [Abstract][Full Text] [Related]
12. Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer.
Wang L; He Y; Liu W; Bai S; Xiao L; Zhang J; Dhanasekaran SM; Wang Z; Kalyana-Sundaram S; Balbin OA; Shukla S; Lu Y; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Chinnaiyan AM; Beer DG; Zhang J; Chen G
Oncotarget; 2016 Mar; 7(10):11487-99. PubMed ID: 26862852
[TBL] [Abstract][Full Text] [Related]
13. Silencing of lncRNA LINC00857 Enhances BIRC5-Dependent Radio-Sensitivity of Lung Adenocarcinoma Cells by Recruiting NF-κB1.
Han F; Yang S; Wang W; Huang X; Huang D; Chen S
Mol Ther Nucleic Acids; 2020 Dec; 22():981-993. PubMed ID: 33251047
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
Zhang Y; Li Y
Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
18. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
19. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
20. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway.
Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
